0001209191-18-020353.txt : 20180316 0001209191-18-020353.hdr.sgml : 20180316 20180316181215 ACCESSION NUMBER: 0001209191-18-020353 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20180316 DATE AS OF CHANGE: 20180316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howton David T CENTRAL INDEX KEY: 0001529297 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 18696963 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-15 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001529297 Howton David T 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 SVP, General Counsel Common Stock 2018-03-15 4 M 0 23 13.71 A 29321 D Common Stock 2018-03-15 4 F 0 3 81.22 D 29318 D Common Stock 2018-03-15 4 M 0 403 13.90 A 29721 D Common Stock 2018-03-15 4 F 0 68 81.22 D 29653 D Common Stock 2018-03-15 4 M 0 2074 23.85 A 31727 D Common Stock 2018-03-15 4 F 0 609 81.22 D 31118 D Stock option (right to buy) 13.71 2018-03-15 4 M 0 23 0.00 D 2017-02-28 2026-02-28 Common Stock 23 70 D Stock option (right to buy) 13.90 2018-03-15 4 M 0 403 0.00 D 2016-02-27 2025-02-27 Common Stock 403 5590 D Stock option (right to buy) 23.85 2018-03-15 4 M 0 2074 0.00 D 2013-11-05 2022-11-05 Common Stock 2074 13018 D The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an "option swap" enables the exercise and holding of shares of Common Stock by the Reporting Person. /s/ David Tyronne Howton 2018-03-16